Tag: Dyslipidemia Therapeutics Market

Dyslipidemia Therapeutics Market Trends And Drivers The Dyslipidemia Therapeutics Market size was valued at USD 14.4 Billion in 2022 and is projected to reach USD 28.7 Billion by 2030, growing at a CAGR of 9.3% from 2024 to 2030. The market growth is driven by the increasing prevalence of dyslipidemia globally, particularly in aging populations, […]